Advertisement

PharmacoEconomics & Outcomes News

, Volume 819, Issue 1, pp 10–10 | Cite as

Betrixaban for VTE prophylaxis: better outcomes, lower cost

Clinical study
  • 3 Downloads

Reference

  1. Guy H, et al. Cost-Effectiveness of Betrixaban Compared with Enoxaparin for Venous Thromboembolism Prophylaxis in Nonsurgical Patients with Acute Medical Illness in the United States. PharmacoEconomics : 21 Dec 2018. Available from: URL: http://doi.org/10.1007/s40273-018-0757-8

Copyright information

© Springer Nature Switzerland AG 2019

Personalised recommendations